Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
September 11, 2014 11:15 AM 3 min read

WholeHealth Products announces the release of the FDA Cleared "Troponin I" rapid test

by PRNewswire
Follow
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Press Releases
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter

ANAHEIM, Calif., Sept. 11, 2014 /PRNewswire/ -- Headquartered in Anaheim, California, WholeHealth Products (OTC: GWPC) is a diversified company comprised of several specialized partners focused on leveraging the power and convenience of advanced technology and the proven expertise of its team of professionals to improve the fundamental business of health and wellness. WholeHealth Products' line of more than 10 professional diagnostic tests for hospitals, doctors, clinics and healthcare centers, and its more than 8 retail consumer tests is proud to announce an addition to its line of rapid diagnostic tests.

The Troponin I Whole Blood/Serum Test is an immunoassay for the rapid qualitative detection of cardiac troponin I (cTnl) in human whole blood or serum at a cutoff level of 1.5 ng/mL.It provides an aid in the diagnosis of myocardial infarction in emergency room, point­ of-care, and hospital setting. Several cardiac markers have been used for  the  diagnosis  of acute  myocardial  infarction {AMI} in the past decade, such as creatine kinase (CK), the MB isoform of creatine kinase (CKMB), lactate dehydrogenase (LOH) isoforms, myoglobin, and cardiac troponins (cTn). Cardiac Troponins exist as a ternary complex with three subunits: cardiac troponin I {cTnl), T (cTnT) and C (cTnC). Investigations showed that both cTnl and cTnT were superior to any of the other cardiac markers because they demonstrated increased sensitivity (>98% at peak concentration) and specificity (95-100%) for AMI over other traditional markers, or even compared to the WHO criteria.

cTnl is released into the blood circulation with levels exceeding the upper reference limit of normal 4-6 hours after the onset of AMI and reaches a peak after 12-24 hours. The high level of cTnl remains for up to 5-7 days. The early release and long duration of cTnl make the test more suitable for the diagnosis of myocardial infarction.

The troponin test is used to help diagnose a heart attack, stroke, TIA's, blood thinning/clotting, determining if the heart is ok for blood thinning  medications,  to detect and evaluate mild to severe heart injury, and to distinguish chest pain that may be due to other causes. In those who experience heart-related chest pain, discomfort, or other symptoms and do not seek medical attention for a day or more, the troponin test will still be positive if the symptoms are due to heart damage. 

Inspired by its slogan, "Love Life Live Long,"  WholeHealth is committed to building long term relationships with the medical and healthcare professional and the patients, helping saves lives. 

www.wholehealth-products.com

WholeHealth Products is your partner in the "Business of Science".

Certain information set forth in this fact sheet may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of WholeHealth Products Inc, including, but not limited to, risks associated with the impact of general economic conditions, industry conditions, dependence upon regulatory approvals, and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.

Photo - http://photos.prnewswire.com/prnh/20140910/145188

SOURCE WholeHealth Products Inc.

Comments
Loading...